Country Profile

Yemen

Yemen is a growing market for Indian pharmaceuticals — $72.0M in FY 2025–26. Medicines accounts for 85% of shipments, with vaccines contributing $4.91M. The compound annual growth rate since FY2015 stands at 3.5%.

🇾🇪 $72.0M · 1.5× growth since FY2015 · 3.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$72.0M
Exports FY2025–26 DGCIS
1.5×
Growth FY2015→2026
3.5%
CAGR FY2015→2026
85%
Medicines Share
5
Product Categories Supplied
Yemen is a growing market for Indian pharmaceuticals — $72.0M in FY 2025–26. Medicines accounts for 85% of shipments, with vaccines contributing $4.91M. The compound annual growth rate since FY2015 stands at 3.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $61.1M (84.9%) Vaccines $4.91M (6.8%) Medicine Ingredients $3.40M (4.7%) Traditional & Herbal $1.45M (2.0%) Surgical & Hospital Supplies $1.09M (1.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Yemen in the RBI overseas direct investment dataset (2011–2026).